BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 9856411)

  • 1. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.
    Barnes RB
    J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome.
    Barnes RB
    Semin Reprod Endocrinol; 1997 May; 15(2):159-68. PubMed ID: 9165659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroidogenesis in human polycystic ovary.
    Mahajan DK
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):751-69. PubMed ID: 3143567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine Regulation of Steroidogenesis in Theca Cells by Granulosa Cells Derived from Mouse Preantral Follicles.
    Liu X; Qiao P; Jiang A; Jiang J; Han H; Wang L; Ren C
    Biomed Res Int; 2015; 2015():925691. PubMed ID: 26357661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal-epithelial cell interactions in the ovary: estrogen-induced theca cell steroidogenesis.
    Roberts AJ; Skinner MK
    Mol Cell Endocrinol; 1990 Jul; 72(1):R1-5. PubMed ID: 2272402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiopathology of polycystic ovary syndrome].
    Dewailly D
    Ann Endocrinol (Paris); 1999 Jul; 60(2):123-30. PubMed ID: 10456184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts of polycystic ovary syndrome.
    Rosenfield RL
    Baillieres Clin Obstet Gynaecol; 1997 Jun; 11(2):307-33. PubMed ID: 9536213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
    Baskind NE; Balen AH
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
    Allon MA; Leach RE; Dunbar J; Diamond MP
    Fertil Steril; 2005 Apr; 83 Suppl 1():1319-26. PubMed ID: 15831308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine control in polycystic ovary-like syndrome.
    Schoemaker J
    Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sites of androgen overproduction in the polycystic ovary (author's transl)].
    Fujita Y; Mori T; Aso T; Nishimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):706-12. PubMed ID: 7240854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of ovarian follicular development in female rat: LH decreases FSH sensitivity during preantral-early antral transition.
    Orisaka M; Hattori K; Fukuda S; Mizutani T; Miyamoto K; Sato T; Tsang BK; Kotsuji F; Yoshida Y
    Endocrinology; 2013 Aug; 154(8):2870-80. PubMed ID: 23709086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome.
    Gilling-Smith C; Story H; Rogers V; Franks S
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):93-9. PubMed ID: 9302378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro.
    McNatty KP; Makris A; DeGrazia C; Osathanondh R; Ryan KJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):687-99. PubMed ID: 489711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism.
    Smyth CD; Miró F; Whitelaw PF; Howles CM; Hillier SG
    Endocrinology; 1993 Oct; 133(4):1532-8. PubMed ID: 8404591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.